CD4 and neoplasm: Extended Data Fig. 5C shows the proportion of regulatory T (Treg) cells in combination evodiamine and PD-1 mAb treatment (CD4+FoxP3+T cell) in the spleen, blood and tumor is decreased (Fig. 6f and Extended Data Fig. 5).